Cynthia Ann Moylan, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 905 S Lasalle St, Gsrb1, DUMC 3256, Durham, NC 27710
Phone (919) 668-0401
Email address cynthia.moylan@duke.edu

My research interests focus on the study of chronic liver disease and primary liver cancer, particularly from nonalcoholic fatty liver disease (NAFLD).  As part of the NAFLD Research Team at Duke, I am investigating the role of epigenetics and genetics on the development of advanced fibrosis from NAFLD.  The long term goal of our research is to develop non-invasive biomarkers to identify those patients at increased risk for cirrhosis and end stage liver disease in order to risk stratify patients as well as to develop better preventative and therapeutic strategies.  

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 2005 - 2009
  • Resident, Medicine, Duke University, 2002 - 2005
  • M.D., University of Miami, 2002

Publications

Patel, YA, Gifford, EJ, Glass, LM, Turner, MJ, Han, B, Moylan, CA, Choi, S, Suzuki, A, Provenzale, D, and Hunt, CM. "Correction to: Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration." Digestive Diseases and Sciences (July 24, 2018).

PMID
30043282
Full Text

Wildman-Tobriner, B, Middleton, MM, Moylan, CA, Rossi, S, Flores, O, Chang, ZA, Abdelmalek, MF, Sirlin, CB, and Bashir, MR. "Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis." Gastroenterology (July 19, 2018).

PMID
30031769
Full Text

Patel, YA, Gifford, EJ, Glass, LM, Turner, MJ, Han, B, Moylan, CA, Choi, S, Suzuki, A, Provenzale, D, and Hunt, CM. "Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration." Digestive diseases and sciences (May 19, 2018).

PMID
29779083
Full Text

Oloruntoba, OO, and Moylan, CA. ""Too Female" for liver transplantation." Hepatology (Baltimore, Md.) (April 20, 2018).

PMID
29679376
Full Text

Wegermann, K, Diehl, AM, and Moylan, CA. "Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis." Clinical Liver Disease 11, no. 4 (April 2018): 87-91.

Full Text

Moylan, CA, and Abdelmalek, MF. "Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis." Hepatology (Baltimore, Md.) (March 13, 2018).

PMID
29534302
Full Text

Patel, YA, Gifford, EJ, Glass, LM, McNeil, R, Turner, MJ, Han, B, Provenzale, D, Choi, SS, Moylan, CA, and Hunt, CM. "Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration." Alimentary Pharmacology & Therapeutics 47, no. 2 (January 2018): 268-278.

PMID
29115682
Full Text

Moylan, CA, Mavis, AM, Bashir, MR, Malik, D, Bozdogan, E, Buie, S, Hoyo, C, Diehl, AM, Murphy, SK, and Abdelmalek, MF. "Visceral and subcutaneous adipose tissue measurements associate with increased metabolic risk for NAFLD in pre-pubertal obese children." October 2017.

Scholars@Duke

Patel, YA, Gifford, E, Glass, LM, McNeil, R, Turner, MJ, Han, B, Provenzale, DT, Choi, SS, Moylan, CA, and Hunt, CM. "Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA)." October 2017.

Scholars@Duke

Li, X, Moylan, CA, Baker, SS, Liu, W, Baker, RD, Murphy, SK, Abdelmalek, MF, Zhu, R, Diehl, AM, and Zhu, L. "Altered liver methylome and transcriptome provide evidence for epigenetic contribution to NAFLD pathogenesis." October 2017.

Scholars@Duke

Pages